Haidian Maternal and Child Healthcare Hospital Trials

Haidian Maternal and Child Healthcare Hospital	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Wang, Qi

NCT04201808: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

Recruiting

100

RoW

Tenofovir Alafenamide 25 MG, Vemlidy

New Discovery LLC, Beijing Ditan Hospital

Hepatitis B, Chronic

09/23

NCT05580354: Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Not yet recruiting

RoW

BCG combined with Tislelizumab

Ruijin Hospital

Non-muscle-invasive Bladder Cancer

10/24

05/25

ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

APPROACH, NCT04841811: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model.

Recruiting

192

RoW

Almonertinib, ctDNA dynamic monitoring guided the Almonertinib treatment

Guangdong Association of Clinical Trials, Jiangsu Hansoh Pharmaceutical Co., Ltd.

Lung Cancer

12/24

12/26

NCT05470413: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Active, not recruiting

330

RoW

SHR0302, Placebo

Reistone Biopharma Company Limited

Alopecia Areata

10/23

02/24

NCT05102149: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Recruiting

672

RoW

PB-201, Vildagliptin, PB-201 matched placebo, Vildagliptin matched placebo

PegBio Co., Ltd.

Type 2 Diabetes Mellitus (T2DM)

11/23

04/25

HERIZON-GEA-01, NCT05152147 / 2021-000296-36: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Active, not recruiting

920

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

CHILL-1, NCT06663631: Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Recruiting

RoW

chlorpromazine and promethazine, C+P, lytic cocktail, Placebo group, Control group, endovascular thrombectomy, rt-PA, Intravenous thrombolysis

Capital Medical University, Linyi People's Hospital

Acute Ischemic Stroke

01/25

02/25

EFED, NCT04182503: Environmental Factors and Embryonic Development Project

Recruiting

N/A

100000

RoW

No intervention

Nanjing Jinling Hospital, Peking University, Sun Yat-sen University, Shandong University, Zunyi Medical College, Zhejiang University, Huazhong University of Science and Technology

Spontaneous Abortion, Fetal Death, Stillbirth, Birth Defects, Preterm Birth, Low Birth Weight, Pregnancy With Medical Condition (Non-Specific), Gestational Diabetes, Gestational Hypertension

12/21

12/22

NCT02515474: Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

Completed

N/A

1000

RoW

Laparoscopy, Laparoscopic common bile duct exploration (LCBDE), Endoscopy, Endoscopic Retrograde cholangiopancreatography (ERCP)

Hepatopancreatobiliary Surgery Institute of Gansu Province

Choledocholithiasis

01/24

NCT05947461: Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac

Terminated

N/A

1204

RoW

100mg diclofenac, 100mg indomethacin

Air Force Military Medical University, China

Post-ERCP Acute Pancreatitis, NSAIDs, Indomethacin, Diclofenac, Endoscopic Retrograde Cholangiopancreatography

06/24

NCT04860154: Photodynamic Therapy for Cholangiocarcinoma

Recruiting

N/A

200

RoW

Hematoporphyrin, ERCP stents

Hepatopancreatobiliary Surgery Institute of Gansu Province

Cholangiocarcinoma Non-resectable

05/24

NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA

Recruiting

N/A

492

RoW

LI YAN

T2DM

12/25

07/26

NCT06760273: Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Recruiting

N/A

364

RoW

No Intervention: Observational Cohort

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

12/27

NCT06777485: China Liver Cancer Clinical Registry Cohort Database

Recruiting

N/A

10000

RoW

Procedure/Surgery treatment, Anti-Tumor Drugs

Anhui Provincial Hospital

Liver Cancer

01/35

NCT06773221: The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Not yet recruiting

N/A

195

RoW

Chiglitazar 64mg, Placebo

Beijing Friendship Hospital, Beijing Ditan Hospital, Peking University People's Hospital, Beijing YouAn Hospital

Metabolic Dysfunction Associated Fatty Liver Disease, Compensated Liver Cirrhosis

01/28

06/28

MAPASD, NCT05746468: Mindfulness Intervention for Parents of Children With ASD

Not yet recruiting

N/A

526

Ecological assessment and intervention, Audio-based Mindfulness intervention

The University of Hong Kong

Mindfulness

07/25

12/25

mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting

N/A

10000

RoW

Installation or registration of smartphone application

Chinese Alliance Against Lung Cancer

Solitary Pulmonary Nodule

10/25

NCT06123858: Non-alcoholic Steatohepatitis Registry Platform Study

Recruiting

N/A

2500

RoW

AstraZeneca

NASH With Fibrosis

12/26

NCT05947162: Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism

Not yet recruiting

N/A

150

RoW

extinction training (nicotine cues), extinction training (neutral cues), Time-restricted smoking cessation, Time-restricted fasting, Dietary intervention, Time-restricted fasting with food supplemnet

Shenzhen Kangning Hospital

Tobacco Use Disorder

07/27

NCT06095037: Mindful Yoga for Older Adults and Caregivers

Not yet recruiting

N/A

668

RoW

Mindful yoga, Psychoeducation

The University of Hong Kong

Psychological

03/28

09/28

NICCE, NCT05028231: Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

Recruiting

N/A

RoW

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy

Tongji Hospital, National Natural Science Foundation of China

Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapies

12/22

12/24

NCT05707585: Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

Recruiting

N/A

2064

RoW

Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)

The Second Affiliated Hospital of Dalian Medical University, Fudan University, Zongda Hospital affiliated to Southeast University, West China Hospital, Henan Provincial People's Hospital, First Hospital of China Medical University, Shengjing Hospital, The First Affiliated Hospital of Guangzhou Medical University, Lisen Imprinting Diagnostics, Inc.

Lung Cancer

01/24

07/24

Jin, lei

EFED, NCT04182503: Environmental Factors and Embryonic Development Project

Recruiting

N/A

100000

RoW

No intervention

Nanjing Jinling Hospital, Peking University, Sun Yat-sen University, Shandong University, Zunyi Medical College, Zhejiang University, Huazhong University of Science and Technology

Spontaneous Abortion, Fetal Death, Stillbirth, Birth Defects, Preterm Birth, Low Birth Weight, Pregnancy With Medical Condition (Non-Specific), Gestational Diabetes, Gestational Hypertension

12/21

12/22

RIX, NCT06700863: Screening of Biomarkers and Related Mechanisms for

Recruiting

N/A

200

RoW

Radiation Therapy

The First Affiliated Hospital with Nanjing Medical University, Jinling Hospital, China, Jiangsu Cancer Institute & Hospital

Xerostomia Due to Radiotherapy (Disorder)

07/25

12/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Wang, Qi

NCT04201808: Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

Recruiting

100

RoW

Tenofovir Alafenamide 25 MG, Vemlidy

New Discovery LLC, Beijing Ditan Hospital

Hepatitis B, Chronic

09/23

NCT05580354: Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Not yet recruiting

RoW

BCG combined with Tislelizumab

Ruijin Hospital

Non-muscle-invasive Bladder Cancer

10/24

05/25

ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Recruiting

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

APPROACH, NCT04841811: MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model.

Recruiting

192

RoW

Almonertinib, ctDNA dynamic monitoring guided the Almonertinib treatment

Guangdong Association of Clinical Trials, Jiangsu Hansoh Pharmaceutical Co., Ltd.

Lung Cancer

12/24

12/26

NCT05470413: Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Active, not recruiting

330

RoW

SHR0302, Placebo

Reistone Biopharma Company Limited

Alopecia Areata

10/23

02/24

NCT05102149: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Recruiting

672

RoW

PB-201, Vildagliptin, PB-201 matched placebo, Vildagliptin matched placebo

PegBio Co., Ltd.

Type 2 Diabetes Mellitus (T2DM)

11/23

04/25

Active, not recruiting

920

Europe, Canada, Japan, RoW

Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil

Jazz Pharmaceuticals, BeiGene

Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

05/25

05/26

CHILL-1, NCT06663631: Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Recruiting

RoW

chlorpromazine and promethazine, C+P, lytic cocktail, Placebo group, Control group, endovascular thrombectomy, rt-PA, Intravenous thrombolysis

Capital Medical University, Linyi People's Hospital

Acute Ischemic Stroke

01/25

02/25

EFED, NCT04182503: Environmental Factors and Embryonic Development Project

Recruiting

N/A

100000

RoW

No intervention

Nanjing Jinling Hospital, Peking University, Sun Yat-sen University, Shandong University, Zunyi Medical College, Zhejiang University, Huazhong University of Science and Technology

Spontaneous Abortion, Fetal Death, Stillbirth, Birth Defects, Preterm Birth, Low Birth Weight, Pregnancy With Medical Condition (Non-Specific), Gestational Diabetes, Gestational Hypertension

12/21

12/22

NCT02515474: Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

Completed

N/A

1000

RoW

Laparoscopy, Laparoscopic common bile duct exploration (LCBDE), Endoscopy, Endoscopic Retrograde cholangiopancreatography (ERCP)

Hepatopancreatobiliary Surgery Institute of Gansu Province

Choledocholithiasis

01/24

NCT05947461: Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac

Terminated

N/A

1204

RoW

100mg diclofenac, 100mg indomethacin

Air Force Military Medical University, China

Post-ERCP Acute Pancreatitis, NSAIDs, Indomethacin, Diclofenac, Endoscopic Retrograde Cholangiopancreatography

06/24

NCT04860154: Photodynamic Therapy for Cholangiocarcinoma

Recruiting

N/A

200

RoW

Hematoporphyrin, ERCP stents

Hepatopancreatobiliary Surgery Institute of Gansu Province

Cholangiocarcinoma Non-resectable

05/24

NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA

Recruiting

N/A

492

RoW

LI YAN

T2DM

12/25

07/26

NCT06760273: Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Recruiting

N/A

364

RoW

No Intervention: Observational Cohort

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult

12/27

NCT06777485: China Liver Cancer Clinical Registry Cohort Database

Recruiting

N/A

10000

RoW

Procedure/Surgery treatment, Anti-Tumor Drugs

Anhui Provincial Hospital

Liver Cancer

01/35

NCT06773221: The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Not yet recruiting

N/A

195

RoW

Chiglitazar 64mg, Placebo

Beijing Friendship Hospital, Beijing Ditan Hospital, Peking University People's Hospital, Beijing YouAn Hospital

Metabolic Dysfunction Associated Fatty Liver Disease, Compensated Liver Cirrhosis

01/28

06/28

MAPASD, NCT05746468: Mindfulness Intervention for Parents of Children With ASD

Not yet recruiting

N/A

526

Ecological assessment and intervention, Audio-based Mindfulness intervention

The University of Hong Kong

Mindfulness

07/25

12/25

mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting

N/A

10000

RoW

Installation or registration of smartphone application

Chinese Alliance Against Lung Cancer

Solitary Pulmonary Nodule

10/25

NCT06123858: Non-alcoholic Steatohepatitis Registry Platform Study

Recruiting

N/A

2500

RoW

AstraZeneca

NASH With Fibrosis

12/26

NCT05947162: Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism

Not yet recruiting

N/A

150

RoW

extinction training (nicotine cues), extinction training (neutral cues), Time-restricted smoking cessation, Time-restricted fasting, Dietary intervention, Time-restricted fasting with food supplemnet

Shenzhen Kangning Hospital

Tobacco Use Disorder

07/27

NCT06095037: Mindful Yoga for Older Adults and Caregivers

Not yet recruiting

N/A

668

RoW

Mindful yoga, Psychoeducation

The University of Hong Kong

Psychological

03/28

09/28

Recruiting

N/A

RoW

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy

Tongji Hospital, National Natural Science Foundation of China

Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapies

12/22

12/24

NCT05707585: Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

Recruiting

N/A

2064

RoW

Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)

Lung Cancer

01/24

07/24

Jin, lei

EFED, NCT04182503: Environmental Factors and Embryonic Development Project

Recruiting

N/A

100000

RoW

No intervention

Nanjing Jinling Hospital, Peking University, Sun Yat-sen University, Shandong University, Zunyi Medical College, Zhejiang University, Huazhong University of Science and Technology

Spontaneous Abortion, Fetal Death, Stillbirth, Birth Defects, Preterm Birth, Low Birth Weight, Pregnancy With Medical Condition (Non-Specific), Gestational Diabetes, Gestational Hypertension

12/21

12/22

RIX, NCT06700863: Screening of Biomarkers and Related Mechanisms for

Recruiting

N/A

200

RoW

Radiation Therapy

The First Affiliated Hospital with Nanjing Medical University, Jinling Hospital, China, Jiangsu Cancer Institute & Hospital

Xerostomia Due to Radiotherapy (Disorder)

07/25

12/25



	Diseases Companies Products Productz Mechanisms of Action Sites